All Insights
March 2026·12 min read
The Signal — March 2026
AI Agents Go Enterprise, Cell Therapy Breakthroughs, and Why Product Strategy Needs a Reset
VS
Vikramaditya Singh
AI-First Product Leader · MS/MBA
This month's signal: enterprise AI agents are moving from demos to production, CAR-T therapy hits a pricing inflection point, and the product strategy playbook needs rewriting for an AI-native world.
Key Signals This Month
1
Autonomous agents move from demo to production — agent authority levels are the new org design challenge
2
CAR-T therapy pricing hits inflection — manufacturing economics, not science, was always the bottleneck
3
Product strategy playbook needs rewriting — strategic judgment is the new moat, not PRD writing
Full content for this edition is being prepared. Subscribe to get it delivered.
AI AgentsCell TherapyProduct StrategyHealthcare AIEnterprise AI